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NF-κB regulates neuronal 
ankyrin-G via a negative feedback 
loop
Hans-Georg König1,2, Robert Schwamborn1,2,†, Silke Andresen1, Sinéad Kinsella1,2, 
Orla Watters1,2, Beau Fenner1,‡ & Jochen H. M. Prehn1,2
The axon initial segment (AIS) is a neuronal compartment defined by ankyrin-G expression. We 
here demonstrate that the IKK-complex co-localizes and interacts with the cytoskeletal anchor 
protein ankyrin-G in immunoprecipitation and proximity-ligation experiments in cortical neurons. 
Overexpression of the 270 kDa variant of ankyrin-G suppressed, while gene-silencing of ankyrin-G 
expression increased nuclear factor-κB (NF-κB) activity in primary neurons, suggesting that ankyrin-G 
sequesters the transcription factor in the AIS. We also found that p65 bound to the ank3 (ankyrin-G) 
promoter sequence in chromatin immunoprecipitation analyses thereby increasing ank3 expression and 
ankyrin-G levels at the AIS. Gene-silencing of p65 or ankyrin-G overexpression suppressed ank3 reporter 
activity. Collectively these data demonstrate that p65/NF-κB controls ankyrin-G levels via a negative 
feedback loop, thereby linking NF-κB signaling with neuronal polarity and axonal plasticity.
Expression of the cytoskeletal protein ankyrin-G is critical for the formation of the initial segment of mamma-
lian central and peripheral axons (AIS), where it serves as the central scaffold1,2. More than 25 splice variants of 
ankyrin-G have been characterized in rodents with 270 and 480 kDa variants representing the most abundant 
isoforms at the AIS1,3,4.
Ankyrin-G protein isoforms are comprised of several membrane-binding and protein-protein inter-
action domains1,3. These allow ankyrin-G to act as a potent multi-domain scaffold, for instance to sequester 
sodium-channels and potassium-channels at the axon initial segment5–7. Accumulation of these ion channels 
and their accessory molecules is critical for spike initiation, form and frequency and hence represents a critical 
determinant of neuronal excitation6,8. Modulation of ankyrin-G levels and activity-dependent relocation is an 
important process as it regulates axonal excitability in a calcium-dependent manner9.
Ankyrin-G also co-operates with the spectrin-actin-network through interacting with βIV-Spectrin2,10 and 
forms cytoskeletal and cytosolic diffusion barriers at the initial segment11–14. These diffusion barriers are critical 
for axonal identity, as loss of ion channel accumulation15 and conversion of axons to dendrites occurs in response 
to ankyrin-G deletion16. This is also of pathophysiological significance as ischemic or traumatic injury to the axon 
may trigger calpain-dependent degradation of ankyrin-G17–19.
However, while ankyrin-G is crucial for neuronal excitability and axonal identity, little is known how 
ankyrin-G expression levels are regulated. Our understanding of factors regulating ankyrin-G transcription is 
currently limited to FoxJ1 which controls ankyrin-G aided progenitor to ependymal cell maturation20.
The transcription factor nuclear factor-κB (NF-κB) regulates the transcription of a large variety of genes in 
a cell-type and stimulus-dependent manner (reviewed in refs 21–25). We previously showed increased stability 
and decreased activity of NF-κB essential modulator (NEMO), the regulatory subunit of the NF-κB activating 
IκBα-kinase (IKK), following its interaction with the AIS-localized fibroblast growth factor homologous factor 
1b (FHF1b26). We hypothesized that NF-κB is involved in homeostatic regulation of ankyrin-G expression levels. 
We here sought to establish a physiological role for the NF-κB pathway in regulating the axon initial segment, and 
demonstrate that NF-κB controls ankyrin-G levels at the AIS via a negative feedback-loop.
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Figure 1. Ankyrin-G and the IKK-complex accumulate in synaptosomal and lipid fractions in the adult 
neocortex and co-immunoprecipitate. (A) Fresh adult mouse neocortex tissue was isolated and separated 
using gradient centrifugation. Proteins were extracted from cellular fractions and analyzed by Western blotting. 
Note the co-localization of pan-IKKα/β, NEMO and p65/NF-κB immunoreactivities to the ankyrin-G (clone 
463, SCBT) positive lipid fraction. (B) Optical densities (OD) of protein immunoreactivity from all fractions 
were determined and mapped as percentage of total OD of all fractions in bar graphs. (C) Ankyrin-G and the 
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Results
The IKK-complex co-localizes and interacts with ankyrin-G in vitro and in vivo. To determine 
subcellular accumulation of NF-κB pathway proteins in the central nervous system, we used gradient centrifuga-
tion to separate synaptosomal and lipid fractions derived from the adult mouse cortex. Anti-IKKα/β (inhibitor of 
kappa light polypeptide gene enhancer in B-cells, kinase) co-localized with anti-NEMO (NF-κB essential modu-
lator) and anti-p65/NF-κB reactivity in ankyrin-G-positive lipid fractions in addition to synaptophysin-positive 
synaptosomes (Fig. 1A,B). We next determined whether anti-IKKα/β immunoreactivity co-immunoprecipitates 
with anti-ankyrin-G (AnkG). Following pull-down of ankyrin-G proteins from mouse cortical extracts using 
anti-ankyrin-G monoclonal and polyclonal antibodies, anti-IKKα/β immunoreactivities were strongly detected, 
but not found in the lanes of negative control precipitates (Fig. 1C, Suppl. Fig. 1A,C). These findings were val-
idated following reverse immunoprecipitation of IKKβ as well as ankyrinG-eGFP (ankyrinG::enhanced green 
fluorescent protein) pull-down, which co-immunoprecipitated IKKβ-Flag as detected by anti-Flag antibodies 
(Fig. 1D–G, Suppl. Fig. 1B). We then investigated how ankyrin-G and IKK-signalosome components co-local-
ized to the cytoskeleton in the axon initial segment following detergent extraction. IKKγ/NEMO and IKKα/β 
immunoreactivities were retained at the proximal AIS cytoskeleton following Triton X-100- or saponin-mediated 
extraction of cytosolic proteins (Fig. 2A–D). Following overexpression of Flag-tagged IKKβ we found the protein 
was also present in the AIS when detected by anti-Flag antibodies. This localization was preserved following 
detergent extraction, where anti-Flag immunoreactivity co-localized to co-overexpressed ankyrinG-eGFP in the 
cells’ soma and in the AIS (Fig. 2E,F).
Interaction of IKKα/β and ankyrin-G in situ. To further analyze whether anti-IKKα/β epitopes were 
found in molecular proximity (<

40 nm) to ankyrin-G epitopes, we employed proximity-ligation assays (PLA, 
Schematic Fig. 3A). Following plasmid transfection, we found significantly more anti-ankyrin-G & anti-IKKα/β 
PLA-derived spots in ankG-eGFP plus IKKβ overexpressing cortical neurons than we found in control trans-
fected neurons, and notably more than we found in ankG-eGFP or IKKβ plus eGFP expressing neurons or neu-
rons transfected with the unrelated EB1-eGFP vector (Fig. 3B–G), overall suggesting antigen-specific reactions.
Gene silencing of ankyrin-G increases, while overexpression of ankyrin-G decreases NF-κB 
dependent reporter-gene activity. IKKα/β is a positive regulator of p65-phosphorylation and 
NF-κB-dependent transcription. Surprisingly, we found that ankyrin-G overexpression depressed NF-κB activity 
in mature cortical neurons (Fig. 4A), while ankyrin-G small-hairpin vector-mediated depletion significantly 
increased NF-κB reporter gene activity over a period of five days (Fig. 4B,C). We also tested the validity of the 
reporter construct for p65/NF-κB-dependent transactivation by overexpression or knockdown of the transcrip-
tion factor (Fig. 4A,C). Notably, comparable to IKK-complex immunreactivity (Fig. 2), anti-p65 immunoreac-
tivity was preserved following detergent extraction using two different antibodies (Fig. 5A–D). We additionally 
determined that an overexpressed p65 photoactivatable-GFP (p65-paGFP) fusion protein exhibits significantly 
decreased mobility in the AIS when compared to paGFP control. Dynein-dependent microtubule-based trans-
port of p65-eGFP in dendrites was previously reported27,28. Despite the cytoplasmic diffusion barrier in the 
AIS11,29, p65-paGFP mobility in the AIS was comparable to the distal axon and dendrites, suggesting similar 
retention and active transport mechanisms in all three compartments. paGFP mobility was significantly lower in 
the neurites compared to the AIS (Fig. 5E–I). Overall, these results suggested that a pool of neuronal p65/NF-κB 
protein is sequestered by the detergent-insoluble cytoskeleton at the AIS.
p65/NF-κB binds the ankyrin-3 gene promoter sequence and regulates neuronal ankyrin-G 
expression via a negative feedback. Next, we decided to test whether NF-κB transcriptional feedback 
controls ankyrin-G expression levels. We focused on a stretch of about 2000 base pairs around the transcrip-
tion start site (TSS) upstream of exon 1e, expressed in many tissues including the frontal cortex, hippocam-
pus and caudate putamen5, of the mouse ankyrin-G (ank3) gene. The region was identified on ENSEMBL 
(ENSMUSR00000028730) and the eukaryotic promoter database (‘Ank3_1’, epd.vital-it.ch, ref. 30). We examined 
IKK-complex co-immunoprecipitate from adult mouse cortical lysates. Mouse cortices were homogenized 
and minced in Na-Sucrose buffer. Equivalent amounts were used for immunoprecipitation (IP) using anti-
ankyrin-G, control anti-IgG, anti-MAP2 or anti-α-Tubulin antisera, followed by immuno-blotting (IB) using 
anti-ankyrin-G (463), anti-pan-IKKα/β (H-470) and anti-MAP2 antibodies. Full-blot views including spliced 
supernatant control bands in Suppl. Fig. 1A. (D) For the reverse experiment, cortical tissue was processed and 
immunoprecipitated using a rabbit polyclonal antibody to IKKα/β (H-470, SCBT), a rabbit polyclonal anti-
IgG antiserum served as control. Rabbit-polyclonal antibodies against ankyrin-G (S.E. Lux) and an alternative 
commercial antibody raised against ankyrin-G (H-215) were applied to additional samples. Following 
electrophoresis and immunoblotting, anti-ankyrin-G (S.E. Lux) and anti-pan-IKKα/β (H-470) antibodies were 
applied in Western-blotting. Full-blot views included in Suppl. Fig. 1B. (E) The relative OD of anti-IKKα/β 
immunoreactivity of all three Ankyrin-G IP’s (Fig. 1C,D and Suppl. Fig. 1C) was plotted against respective 
IgG-control IPs. (F) Anti-GFP antibodies pulled Flag-tagged IKKβ down from ankG-eGFP co-transfected, 
but not eGFP co-transfected cells. AnkyrinG-eGFP pull-down experiments were conducted following a 2-day 
transfection of SH-SY5Y cells with ankG-eGFP and IKKβ-FLAG vectors. Tag-specific antibodies were used to 
detect the proteins following Western-blotting procedure. (G) Quantification of anti-FLAG immunoreactivity 
(ODs representing IKK-β) depicted in (F) and three additional, similarly conducted pull-down experiments was 
determined.
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the sequence for potential p65/NF-κB binding sequences using an established promoter search algorithm 
(<15% dissimilarity margin, TESS, Fig. 6A). Contained in this area we found 4 potential binding sites for p65/
NF-κB. Following brief stimulation of a mouse cell line with tumor necrosis factor-α for appropriate NF-κB 
induction, we used primer pairs surrounding the previously identified areas in chromatin immunoprecipitation 
Figure 2. The IKK-complex co-localizes with ankyrin-G to the axon initial segment. (A–D) Cortical neurons 
were cultured until maturity in vitro and were cytosol-extracted for the visualization of cytoskeletal-associated 
proteins. They were incubated for 5 minutes in 1% (m/V) Triton-X-100 (A–C) or 0.5% saponin (D) in 10 mM 
Na3PO4-buffer (pH 7.4), 1 mM MgCl2, 3 mM CaCl2, 150 mM NaCl. Extractions were performed at 4 °C, prior 
to fixation and immunostaining. Anti-IKKγ/NEMO immunoreactivity is highlighted in red (A) or green (B), 
the AIS-specific marker44 antibody 14D4 (green,A) or anti-AnkG (red, B) were used to identify the AIS (green). 
(C,D) Extractions were similarly performed followed by immunolabeling using pan-IKKα/β - specific antibodies 
(red, rabbit polyclonal, H-470, SCBT) with the AIS labeled by anti-ankyrinG in green. Color overlays are depicted 
following background substraction and sharpening, arrows highlight AISs, scale bars, 10 μm. (E) IKKβ-Flag and 
eGFP vectors were transfected into mouse cortical neurons on DIV13 using Ca-precipitation. 2 days following 
transfection, neurons were fixed and immunolabeled using a rabbit polyclonal anti-Flag-specific antibody 
(Sigma, red), as well as a mouse monoclonal ankyrin-G-specific antibody (Zymed). Note the Flag-tag-specific 
immunoreactivity within the ankyrin-G positive AIS stretch (arrow, yellow). (F) IKKβ-Flag and ankG-eGFP vectors 
were transfected into mouse cortical neurons as above. 2 days following transfection neurons were cytosol-extracted 
for visualization of cytoskeletal-associated proteins by incubation in 1% (m/V) Triton-X-100 buffer for 5 minutes. 
Extractions were performed using pre-cooled solutions and performed at 4 °C, prior to fixation and immunostaining. 
Note that overfixation often obliterates AIS-immunoreactivity. The inset shows a magnified view of the anti-Flag 
positive AIS. Note that ankG-eGFP and anti-Flag reactivity remained associated with the non-soluble cytoskeleton in 
both, in the AIS (arrow), but also in spots within the soma following Triton-X100 extraction. The ankyrin-G antibody 
showed a notably stronger immunolabeling in the ankG-eGFP transfected cell than in the surrounding untransfected 
control cells. Scale bars, 10 μm.
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assays (ChIP) using a rabbit monoclonal antibody raised against p65/NF-κB tested for application in ChIP 
(D14E12). We obtained pronounced amplification from two regions containing potential NF-κB binding sites 
proximal to the TSS (‘4&6’, ‘32&33’, Fig. 6B). NF-κB/p65 dependent regulation of ank3 transcripts was deter-
mined by depletion of p65 in PC12 cells. Abundance of transcripts was decreased by small-hairpin mediated 
reduction of p65 protein levels, while ankG-eGFP overexpression confirmed primer specificity (Fig. 6C). We 
then inserted the ank3 promoter sequence upstream of a firefly-luciferase reporter gene in order to test whether 
p65/NF-κB induced ank3-promoter dependent reporter activity. p65-cotransfected PC12 cells showed a pro-
nounced and significant up-regulation of luciferase activity from the above reporter construct which was not 
observed following eGFP transfection or p65 reduction (Fig. 6D). Upon further split into proximal and distal 
promoter constructs (Schematic Fig. 6A), we found pronounced p65-dependent and IKKβ-potentiated activity 
from the proximal region mainly in primary cortical neurons, in agreement with the results from the ChIP anal-
yses (Fig. 6E). Additional experiments using the full-length promoter construct in primary cortical neurons con-
firmed the previous results obtained from PC12 cells (Fig. 6F), and showed that basal ank3-reporter gene activity 
was diminished in p65-depleted cells (Fig. 6G). We also tested whether transfection of phospho-site mimetics 
potentiates ankyrin-G protein expression at the AIS of primary neurons. Interestingly, following a 3-day period 
of expression, we found a significant increase of the ankyrin-G intensities by transfection of p65-S536D mutants 
(Fig. 6H,I). Consistent with decreased p65/NF-κB activity following overexpression of ankyrin-G, we found nota-
bly decreased ank3-dependent reporter activity following overexpression of the scaffolding protein (Fig. 6J).
Figure 3. Proximity-ligation assays (PLA) indicate molecular proximity between IKKα/β and ankyrin-G. 
(A) Principle of proximity-ligation assays to detect proximity of the IKK-complex and ankyrin-G. 
Oligonucleotide-labeled antibodies hybridize and are amplified via rolling-circle amplification when in 
molecular proximity (<

40 nm). (B–E) Panels depicts mature cultured cortical neurons transfected with eGFP, 
EB1-eGFP, as negative control or ankG-eGFP with or without IKKβ expression plasmids. PLA between anti-
EB1-anti-panIKKα/β as negative control, or anti-ankyrin-G and anti-panIKKα/β epitopes, was conducted 
using anti-mouse and anti-rabbit specific antibodies. Arrows depict PLA-reactivity in the axon. The experiment 
was repeated under similar conditions with comparable results. (G) Somatic and proximal PLA-spots were 
counted from 3-183 transfected and un-transfected cells pooled from 1–2 experiments. Kruskal-Wallis, Dunn’s 
post-hoc test. Scale bars 10 μm.
www.nature.com/scientificreports/
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Discussion
Neuronal plasticity allows the nervous system to adapt to intrinsic and extrinsic cues. Recent evidence suggests 
a novel form of plasticity owing to alterations of positioning and length of the axon initial segment (AIS)31,32. 
The AIS integrates information from somatodendritic, axo-axonic and inhibitory input, and computes axonal 
output based on the molecular make-up and positioning of this compartment8,31,33. These properties may explain 
its recently emerging involvement in the pathophysiology of neurodevelopmental disorders such as Angelman 
syndrome34, bipolar disorder35–37, intellectual disability38 and posttraumatic stress disorder39 (reviewed in ref. 40).
The transcription factor NF-κB was found in the axoplasm41–43. Previous studies described an accumula-
tion of phosphorylated NF-κB pathway proteins at the AIS of rodents and humans in vitro and in vivo44. 
Immunoreactivity to phosphorylated IκBα and activated IKK has been found at nodes of Ranvier45 and both 
proteins were implicated in axon outgrowth46. Despite the proposed key role of the AIS in neuronal physiol-
ogy and pathophysiolgy, little is known about the transcriptional regulation of its main components. Here, we 
found that ankyrin-G and IKKα/β co-localized in membrane and synaptosomal fractions of mouse cortical 
extracts and co-immunoprecipitated from cortical lysates, also evidenced in the reverse co-immunoprecipitation 
and pull-down experiments. Membranes were extracted using the mild detergent IGEPAL CA-630, as previ-
ously employed in co-immunoprecipitation work on the membrane-associated ankyrin-spectrin network47. 
In IκBα knockout mice persistent staining for phosphorylated IκBα48 was shown, raising concerns regarding 
phosphorylation-specific antibody specificity. A potential compensatory up-regulation or cross-reactivity to 
phosphorylated IκB isoforms have not been determined in the cited study. Whole protein, pan-specific poly-
clonal antibodies are considered less promiscuous compared to phosphorylation-specific antibodies. Here we 
found that the IκBα-upstream kinase complex associated with detergent-insoluble cytoskeletal compartments 
and demonstrate that pan-IKKγ and pan-IKKα/β co-localized with ankyrin-G. Previous studies suggested that 
IKKγ/NEMO also localized to the AIS cytoskeleton following detergent extraction, and demonstrated that it 
interacted with AIS-localized FHF1/FGF12 (fibroblast growth factor homologous factor 1)26. Furthermore, 
IKK-complex inhibitors also inhibited the interaction of sodium channels with FHF4/FGF14, both also localized 
at the AIS49,50. Collectively, these data suggest that IKK signaling components localize to the AIS.
Importantly, the co-localization of ankyrin-G and IKKα/β was consolidated in proximity-ligation assays, 
thus validating their proximity in the molecular range (smaller than about 40 nm51). This interaction signifi-
cantly increased following overexpression of both proteins. Ankyrin-G contains ankyrin- and death-domains 
(DDs) that may serve as scaffolds upstream of NF-κB activation. DD interactions form platforms that either 
result in apoptosis52 or signal towards NF-κB. Depending on the nature of the scaffold they either decrease53 
or potentiate transcription factor activity54. Interestingly, we here show that ankyrin-G-eGFP expression 
Figure 4. Ankyrin-G negatively regulates NF-κB reporter-gene activity. (A) AnkG-eGFP inhibits neuronal 
constitutive NF-κB61 activity. Mature cortical neurons were transfected with ankG-eGFP or p65-eGFP and  
κB-dependent luciferase reporter activity was monitored in Dual-Luciferase assays (n = 13–19 wells pooled 
from 3 experiments, Kruskal-Wallis followed by Dunn’s test). (B) Efficient suppression of ankyrin-G expression 
at the axon initial segment following transduction with ankyrin-G-specific small-hairpin RNA. Mature 
cortical neurons were transfected with ankyrin-G shRNA or control vector together with eGFP for 5 days 
and immunolabeled. Scale bar, 10 μm. Note transfected ankyrin-G positive AIS marked by arrow or negative 
cell bodies marked by asterisk. One transfected cell is shown magnified in the boxed area. (C) Depletion 
of ankyrin-G expression in mature cortical neurons induces NF-κB activity. Mature cortical neurons were 
transfected with ankG- or p65-specific shRNA together with Dual-Luciferase reporter plasmids for 5 days and 
κB-dependent reporter gene expression was determined (n = 12 wells pooled from 2 experiments, Kruskal-
Wallis, Dunn’s post-hoc test, experiment was repeated 2 times with equivalent results).
www.nature.com/scientificreports/
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Figure 5. The transcription factor p65/NF-κB localizes to the axon initial segment. (A–D) Mature 
cortical neurons were cytosol-extracted using a Triton-X100-based buffer. Extractions were performed at 
4 °C. Then, neurons were either immunolabeled using a rabbit monoclonal anti-p65 (green, D14E12, CST), a 
rabbit monoclonal anti-cJun (green, Cell Signaling Technology) or a mouse monoclonal p65/NF-κB-specific 
antibody (green, pan-p65, F-6, SCBT) together with either mouse monoclonal (413) or rabbit polyclonal 
ankyrin-G-specific (H-215, both SCBT) antibodies. AIS highlighted by arrows. (D) Experiment was conducted 
www.nature.com/scientificreports/
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decreased NF-κB activity in cortical neurons, suggesting that p65 availability is reduced following sequestration 
by the ankyrin-repeats of ankyrin-G in a manner similar to IκBα-ankyrin-repeat domain sequestration of the 
p65-Rel-homology domain55. In turn we found that increased levels of p65 activated the NF-κB-reporter follow-
ing silencing of ankyrin-G. We also found p65 to be associated with the AIS cytoskeleton. p65 immunoreactivity 
was previously described in the axoplasm41–43 and was activated following sciatic nerve transection56. In further 
studies, we found that ank3 transcripts and reporter-gene expression were regulated in an NF-κB dependent 
manner, thus potentially allowing for a modulation of ankyrin-G length and position along the AIS9,31,32,57 and 
its expression levels at spine heads58. Database queries suggest several transcription start sites for the rodent ank3 
gene. Ankyrin-G isoform expression may be regulated not only through alternative splicing but also through 
alternative start sites. Notably, shorter variants occur post-synaptically and help in the organization of nanodo-
mains at glutamatergic synapses58. It has previously been demonstrated that ischemic injury resulted in the disas-
sembly of the ankyrin-G-related AIS-cytoskeleton, which began at early time-points following the insult, and was 
inhibited by a calpain inhibitor17. Interestingly, neurons that were completely devoid of the AIS diffusion barrier 
failed to re-establish a functional AIS. More recent work implicated P2X7 receptors in the calpain-dependent 
ankyrin-G depletion following CNS insults59. Our findings suggest that increasing the activity of the transcription 
factor NF-κB may up-regulate a set of ankyrin-G transcripts and protein under such pathophysiological condi-
tions, thereby preventing injury-induced AIS disassembly and promoting spine maintenance.
In conclusion, we demonstrate that p65/NF-κB controls ankyrin-G levels via a negative feedback loop, thereby 
linking NF-κB signaling with neuronal polarity and axonal plasticity. Constitutive NF-κB activity may help to 
maintain ankyrin-G expression levels in differentiated neurons, while sequestration of the transcription factor 
by ankyrin-G may restrict NF-κB overactivity and overabundance of ankyrin-G. This feedback loop may also be 
appropriately positioned to maintain expression levels of ankyrin–G during pathophysiological conditions.
Methods
Chemicals. Chemicals came from Sigma-Aldrich (Wicklow, Ireland) or Merck Chemicals (Nottingham, UK), 
unless stated otherwise. Primers for PCR and cloning applications were obtained from Sigma-Aldrich (Wicklow, 
Ireland). Restriction enzymes were from Fermentas (Life Technologies, Dun Laoghaire, Ireland) or New England 
Biolabs (New England Biolabs, Brennan&Co., Stillorgan, Ireland). TNF-α was from PeproTech, London, UK. Cell 
culture media was purchased from Gibco-Invitrogen (Dun Laoghaire, Ireland) and pre-designed p65-HuSH-29 
small-hairpin RNA-vector constructs from Origene (Rockville, MD, USA).
Cell Culture. Phaeochromocytoma (PC)12 cells were cultured in RPMI media including 10% Horse serum, 
5% Fetal Bovine Serum (FBS), 2 mM L-Glutamine and 1% Penicillin Streptomycin; SH-SY5Y cells were cultured 
in DMEM/F-12 media, including 10% FBS, 2 mM L-Glutamine and 1% Penicillin/Streptomycin. Cells were kept 
at 37 °C in 5% CO2 in a humidified atmosphere and passaged every 3–5 days. PC12 and SH-SY5Y cells were trans-
fected using Lipofectamine 2000 (Gibco-Invitrogen) or Transit-X2 (Mirus, Madison, WI, USA) or nucleofection 
(Lonza, Tewkesbury, UK) and using standard protocols. Primary cultures from C57BL/6 E16 mouse pups were 
obtained from pregnant mothers, the cortices were isolated, minced and following trituration and trypsin-digest 
for 30 mins at 37 °C, they were cultured for one day in DMEM, 10% FBS, 2 mM Glutamine and then in Neurobasal 
(Gibco), 2% B27, 1% GlutaMAX (Gibco), or NMEM-B27 media (1xMEM, 1 mM sodium pyruvate, 26 mM 
NaHCO3, 2 mM GlutaMAX, 1xB27 and 33 mM β-D-Glucose), including β-D-arabino-furanoside (0.6 μM, 
DIV1–2), for the days-in-vitro (DIV) as indicated. Transfection of primary mature neurons was performed using 
calcium precipitation as previously described26,60. Transfections were conducted on mature cortical neurons 
using pGFP-EB1 (Addgene Plasmid #17234); pFlag-IKK-2 (IKKβ; Addgene #11103); pAnkG-eGFP5 (270 kDa; 
a kind gift of V. Bennett, Duke University Medical Center, Durham, NC, USA); p65-eGFP (a generous gift of E. 
Floettmann and M. Rowe, Cardiff, UK); IκBα-wt (a kind gift of F. Peyron, Inserm 364, Nice, France); p65-wt, 
p65-S536D, p65-S536A (a generous gift of Carl Y. Sasaki, NIH, Baltimore, MD, USA).
Animal procedures were carried out under a license from the Department of Health and Children of Ireland 
(B100/3688) and the Health Products Regulatory authority (HPRA, AE19127/P005), and were previously 
approved by the Research Ethics Committee of the Royal College of Surgeons in Ireland (REC131 & 817).
as in C, with single AIS magnified. Note the labeling of pan-p65 immunoreactivities along the axon initial 
segment. Color overlay is depicted following background substraction. Scale bars, 10 μm. (E) p65-paGFP 
exhibits decreased mobility in the AIS. Following photo-activation of p65-paGFP or paGFP in DIV12–19 rat 
hippocampal neurons, fluorescence intensity decline was monitored. Representative time course images of 
photo-activated p65-paGFP or paGFP in the AIS are depicted. DsRed2 fluorescence (not shown) was used to 
identify the axon initial segment of transfected neurons based on morphological criteria. Times indicate time 
points after photo-activation. Regions marked with blue boxes were irradiated with 405 nm light to photo-
activate the paGFP/p65-paGFP. Note that 1 second after photo-activation, p65-paGFP fluorescence increase 
is mainly confined to the irradiated region, while paGFP fluorescence has already spread over the region’s 
boundaries. Scale bars, 2 μm. (F–H) Traces of mean fluorescence intensity of p65-paGFP and paGFP in the 
irradiated region ±SEM, n = 3–4 experiments, per experiment 6–12 neurons were analyzed. (I) Bar graphs 
depict average time point of over 90% fluorescence intensity reduction after photo-activation in 28–33 neurons 
per group in 3–4 different platings. Time points were determined from data represented in the traces. Neurites 
of similar morphology and widths were imaged (F’–H’). No significant differences were found between paGFP 
and p65-paGFP expressing neurons. n.s.: not significant, one-way ANOVA.
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Immunofluorescence and live-cell analyses. For fixation glass-sealed formaldehyde solutions 
(Mallinkrodt, Dublin, Ireland) were freshly diluted from 16% to 3% content using 1X cytoskeletal buffer (CB 
buffer: 10 mM PIPES (pH 6.8), 150 mM NaCl, 5 mM EGTA, 5 mM glucose, 5 mM MgCl2). Following recovery 
of cell culture media, freshly prepared and pre-warmed (37 °C) formaldehyde solutions were added directly to 
cells, wells were sealed and incubated at 37 °C for 12–20 minutes. Following washes in cold HBSS, cells were per-
meabilized using ice-cold HBSS containing 0.1% (w/v) Triton X-100, blocked with 0.3% (w/v) Triton X-100 and 
5% (v/v) horse serum in HBSS. They were incubated for 2 hours at RT or overnight at 4 °C in primary antibody 
dissolved in 0.3% (w/v) Triton X-100, 1% (v/v) horse serum in HBSS. The following primary antibodies were used, 
mouse monoclonal anti-ankyrin-G (H-4 & 463, 1:500, Santa Cruz Biotechnology (SCBT), Heidelberg, Germany, 
Cat# sc-12719, RRID:AB_2057712; Cat# sc-12719, RRID:AB_626674), a rabbit polyclonal anti-ankyrin-G 
(H-215, 1:1000, SCBT Cat# sc-28561, RRID:AB_633909), a mouse monoclonal ankyrin-G-specific antibody 
Figure 6. p65 increases ank3 promoter-dependent reporter-gene activity. (A) Schematic drawing of a 2 kB 
stretch upstream of the putative transcription start site (TSS) of the mouse ank3 gene containing multiple 
putative NF-κB transcription factor binding sequences. (B) p65/NF-κB binds to the ank3 gene promoter. p65 
ChIP following 2 h TNF-α (100 ng/ml) in mouse BV2 cells, primer numbers surrounding putative NF-κB 
sequences labeled as in (A). (C) qPCR of ank3 transcripts in PC12 cells following depletion of endogenous p65 
protein. PC12 cells were transfected using p65-shRNA or ank3-eGFP vectors and analyzed. Fold-induction 
of ank3 transcripts was determined using 18S rRNA-specific primers for normalization (n = 3). (D) The 
ank3 promoter sequence highlighted in (A) was cloned into a pGL3-luciferase reporter vector and used in 
Dual-Luciferase-assays following transfection of PC12 cells (n = 8–16, Kruskal-Wallis test, Dunn’s post-hoc, 
p = 0.0094). (E) TSS proximal promoters bind p65. Proximal and distal parts of above sequence were similarly 
generated and transfected into mature cortical neurons with IKKβ and p65 expression vectors (n = 4, Mann-
Whitney test within fragments, p ≤ 0.05 (proximal and distal)). (F) Similarly, p65 induces the ank3 promoter 
in primary cortical neurons. These were transfected with p65 and IκBα vectors together with the ankyrin-3-
reporter (n = 6–8 wells, Kruskal-Wallis followed by Dunn’s, p = 0.0003). (G) Depletion of endogenous p65 
suppresses ankyrin-3-reporter activity. Cortical neurons were transfected using control-/p65-shRNA constructs 
together with the ank3-reporter construct for 5 days, relative luciferase activities were determined (n = 6 wells, 
Mann-Whitney test, p = 0.0022). (H) Overexpression of serine536-phospho-mimetic p65-mutants (S536D) 
results in higher ankyrin-G expression at the AIS than wild-type p65. Ankyrin-G immunofluorescence along 
the AIS was determined following three days of transfection. (I) Quantification of the AUC determined from 
the single traces obtained from the p65 mutants in ((H) n = 19–33 axons, Kruskal-Wallis test, Dunn’s post-hoc 
*p = 0.0093). (J) Mature cortical neurons were transfected using the ank3-promoter in conjunction with ankG-
eGFP and lysed after two days. Relative ank3-luciferase activity was determined (n = 8 wells, parametric data 
analyzed by two-sided t-test, p = 0.00315).
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(Thermo Fisher, Paisley, UK, Cat# 33-8800, RRID:AB_2533145, 1:500), a rabbit polyclonal anti-Flag-specific anti-
body (Sigma, Cat# F7425, RRID:AB_439687, 1:500), an anti-(pan)-IKKα/β, (H-470, 1:1000, SCBT, Cat# sc-7607, 
RRID:AB_675667), anti-(pan)-IKKγ/NEMO (1:200, Abcam,Cambridge, UK, Cat# ab77750, RRID:AB_1566331), 
a rabbit monoclonal anti-p65 (D14E12, Cell Signaling Technology (CST), Leiden, Netherlands, Cat# 8242, 
RRID:AB_10859369, 1:500), a mouse monoclonal p65/NF-κB-specific antibody (pan-p65, F-6, SCBT, Cat# 
sc-8008, RRID:AB_628017, 1:500), a rabbit monoclonal anti-c-Jun (60A8, CST, Cat# 9165, RRID:AB_2130165, 
1:500) as well as the antibody 14D4 (rabbit polyclonal, #2859, CST, Cat# 2859, RRID:AB_561111, 1:500). 
Following three washes in ice-cold HBSS, cultures were incubated for 1 hour at RT with secondary antibod-
ies raised against the appropriate species and tagged with either Alexa–Fluor-488 or -568 (Gibco-Invitrogen). 
Photomicrographs were obtained using a SPOT RT SE 6 Camera (Diagnostic Instruments, Sterling Heights, 
USA) on an Eclipse TE 300 inverted microscope (Nikon, Kinston upon Thames, UK) and on a Te2000-s with 
40x magnification with Mercury-arc light bulbs. A Zeiss 510 or 710 LSM (Zeiss, Jena, Germany) was used for 
confocal image analyses. Images were processed and analyzed using ImageJ (1.50 f, NIH, Baltimore, USA) and 
MetaMorph software (version 7.0 and higher, Molecular Devices, Berkshire, UK). Background subtractions were 
applied using the same settings to all images of an experimental image set, where indicated and using the ImageJ 
software routine rolling ball or the Metamorph flatten background routine. Cytosolic extractions were performed 
by incubation of cells for 5 minutes in 1% (m/V) Triton-X-100 or 0.5% saponin in 10 mM Na3PO4-buffer (pH 7.4), 
1 mM MgCl2, 3 mM CaCl2, 150 mM NaCl. Pre-cooled solutions were used and the procedure was performed at 
4 °C, prior to washes in PBS, fixation and immunostaining. Photoactivation experiments were conducted using 
photoactivatable eGFP (a kind gift of G.Patterson and J. Lippincott-Schwartz, The National Institute of Child 
Health and Human Development, NIH, MD USA) on a LSM 5 live Duo confocal microscope. The p65 sequence 
was cloned from a human p65-eGFP vector into a vector encoding photoactivatable eGFP using HindIII and 
BamHI. Neurons were transfected via calcium phosphate precipitation with vectors encoding p65-paGFP or 
paGFP, as well as the red fluorescent protein DsRed2. During photo-activation measurements, neurons were 
maintained in in a buffer (120 mM NaCl, 20 mM HEPES, 12 mM glucose, 5 mM NaHCO3, 3.5 mM KCl, 1.2 mM 
CaCl2, and 0.4 mM KH2PO4; pH 7.4) supplemented with 1.2 mM MgCl2, at 37 °C and atmospheric CO2. paGFP 
was excited using a 489 nm laser diode (100 mW, 4% laser power) and light was collected through a 495–555 nm 
bandpass filter. DsRed2 was excited at 561 nm (40 mW, 4% laser power) and emissions were collected through a 
575 nm long pass filter. For paGFP activation, a 3.3 μm long region was illuminated with 405 nm light from a laser 
diode (50 mW, 100% laser power) for 20 iterations, in total 0.78 s. Images of paGFP fluorescence were acquired 
every 2 s and measurements started 1 min before photo-activation, while finishing 5 min after photo-activation. 
paGFP fluorescence intensity was background subtracted and the resulting traces were corrected for baseline 
slope. For comparison of traces, maximum paGFP fluorescence intensity values were normalized to one, while 
baseline fluorescence was set as zero. Resulting curves of fluorescence loss after photo-activation were fitted using 
equations of second order exponential decay.
Proximity-ligation assays. Proximity-ligation assays to detect antigens in molecular proximity 
were conducted on carefully formaldehyde-fixed primary cortical neurons. Briefly, following standard immu-
nofluorescence procedures including primary antibody incubation, a rabbit anti-IKKα/β (SCBT, Cat# sc-7607, 
RRID:AB_675667, 1:500), anti-EB1 (BD Biosciences, Oxford, UK, Cat# 610534, RRID:AB_3978911:500) or a 
mouse monoclonal anti-ankyrin-G (SCBT, Cat# sc-12719, RRID:AB_626674, 1:500) were used overnight, incu-
bation of Olink-specific plus/minus oligonucleotide-linked antibodies in antibody-dilution buffer followed 
(Duolink, Olink Bioscience, Uppsala, Sweden). Hybridization of oligonucleotides and detection was conducted 
as advised by the manufacturer’s instructions.
Gradient centrifugation for subcellular fractionation. Brains of adult C57BL/6 mice were dounced 
and minced in 5 ml STE-buffer (0.32 M Sucrose, 10 mM Tris, 1 mM EDTA, pH 7.2–7.4, including protease and 
phosphatase inhibitor cocktails (1:100, Sigma)) per brain. 10% and 7.5% Ficoll solutions (Sigma) were prepared 
in ice-cold STE-buffer from 20% Ficoll stock solution and carefully layered. The brain lysates were centrifuged at 
1200 g for 5 minutes, the pellet labeled nuclei was immediately lysed in 5 M urea-SDS-lysis buffer. The supernatant 
of the above step was spun at 11,100 g, the pellet re-suspended and layered on top the Ficoll gradient. Gradient 
centrifugation followed at 100,000 g for 30 minutes using ultracentrifugation (Sorvall, Thermoscientific, UK) and 
a lipid fraction, a synaptosomal fraction as well as a mitochondrial and nuclear fractions were isolated and lysed 
in SDS-lysis or 5 M-urea buffer for Western-blot procedures.
Immunoprecipitation and Western-blotting. For immunoprecipitation, brains were minced using 
dounce-homogenization in ice-cold sodium-sucrose buffer, 140 mM NaCl, 2 mM EDTA, 20 mM Tris (pH 7.4), 
250 mM sucrose, 10 mM β-glycero-phosphate, 50 mM NaF, including protease inhibitor cocktail and phosphatase 
inhibitor cocktail 2&3 and 1% IGEPAL CA-630. Cells were briefly rinsed with ice-cold HBSS (Gibco) includ-
ing protease and phosphatase inhibitors (Sigma-Aldrich; 1:1000), prior to lysis for 1 h on rotation. Lysates were 
cleared by centrifugation at 13,000 rpm for 10–20 minutes before protein determination and immunoprecipi-
tation. We used 250–500 μg of protein lysate as indicated with 5–25 μl of rabbit polyclonal anti-ankyrin-G (a 
kind gift of S.E. Lux, Children’s Hospital, Boston, USA), rabbit polyclonal or mouse monoclonal anti-ankyrin-G 
(H-215; clone463, SCBT) antibody, rabbit polyclonal anti-MAP2 (sc-20172, SCBT, microtubule-associated 
protein-2), or anti-IKKα/β (H-470) antibodies in Na-Sucrose lysis buffer following pre-clearing of the lysates and 
linkage to protein A/G-Agarose beads (SCBT). For GFP-pulldown, following transfection of SH-SY5Y cells and 
lysis in Co-IP buffer (50 mM Tris·Cl, pH 7.5, 15 mM EGTA, 100 mM NaCl, 0.1% (w/v) Triton X-100), 5 or 1 μg 
of a mouse monoclonal anti-GFP (B-2, SCBT, Cat# sc-9996, RRID:AB_627695) was used with 100 μl protein 
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A/G-agarose beads or 50 μl dynabeads protein-G. IKKβ-Flag was detected using a rabbit polyclonal anti-Flag 
(OctA, SCBT, Cat# sc-807, RRID:AB_675756, 1:2000), ankG-eGFP-fusion protein by a rabbit monoclonal 
anti-GFP antibody (E385, Abcam, Cat# ab32146, RRID:AB_732717, 1:2000). Immunoprecipitates were washed 
in lysis buffer and PBS and solubilized in SDS-loading buffer for subsequent Western-blot analyses using standard 
techniques. For Western-blot analyses cells were lysed in RIPA buffer (150 mM NaCl, 1.0% IGEPAL CA-630, 0.5% 
Na-deoxycholate, 0.1% sodium dodecyl sulfate, 50 mM Tris-HCl, pH 8.0, including protease and phosphatase 
inhibitor cocktail). Following standard procedures for cell lysis and protein determination, equal amounts of 
protein were separated by 6–15% gel electrophoresis as appropriate and immunoblotted using semi-dry transfer. 
Following blocking procedures, antibodies were dissolved in Tris-buffered saline, 0.05% Tween-20 and 3–5% 
semi-dry milk. The following antibodies were used in Western blotting, rabbit anti-ankyrin-G (Lux), mouse 
monoclonal anti-ankyrin-G (463, SCBT) antibody, anti-NEMO (1:1000, #ab77750, Abcam), rabbit polyclonal 
anti-ankyrin-G (H-215), anti-pan-p65 (1:5000, F-6X, SCBT, 1:500), rabbit anti-IKKα/β (1:1000, H-470, SCBT), 
mouse monoclonal anti-α-Tubulin (1:5000, Sigma), mouse monoclonal anti-GAPDH (1:1000, 6C5, Abcam, 
Cat# ab8245, RRID:AB_2107448), anti-synaptophysin (Sigma, Cat# SAB4502906, RRID:AB_10746692), rabbit 
polyclonal anti-Lamin A/C (CST, Cat# 2032, RRID:AB_2136278) and a rabbit polyclonal anti-VDAC2 (1:1000, 
Abcam. Cat# ab37985, RRID:AB_778790). Detection was conducted using appropriate HRP-linked secondary 
antibody detection (Jackson Immunoresearch, Newmarket, UK).
Molecular cloning of mouse ank3-promoter firefly luciferase reporter gene and small-hairpin 
constructs directed at mouse ank3 mRNA and qPCR procedure. The following primers were 
used to PCR amplify mouse ank3 gene specific reporter-gene constructs from mouse total DNA preparations. 
5′-GCTAGCTAGCCTTTCCTTGAGATCAGGGGAAGT-3′ and 5′-TTAGGTACCGGGTGGGGCAACCGC-3′, 
with a PCR product size of 1903 bp, which were cloned into pGL3-Basic vector (Promega) using the restric-
tion enzymes, KpnI and NheI (Fermentas, Life Technologies, Dun Laoghaire, Ireland). The amplified sequence 
is located directly upstream and contained in the region encoding exon 1e (ref. 5), expressed in ankyrin-G tran-
scripts of approximately 93 kDa, 192 kDa, 209–214 kDa and also 500 kDa (Addgene Plasmid #86436). Primers for 
obtaining the first and second half segments of the promoter were used in conjunction with the above primers 
to obtain these promoter constructs as follows, 5′-GCTAGCTAGCCTGGCTTTTTCTGTGCCAGAA-3′ and 
5′-TTAGGTACCTTCTGGCACAGAAAAAGCCAG-3′. Amplified sequences were verified by sequencing using 
RV3 standard sequencing primers (MWG, Germany). For preparation of the ankyrin-3 mRNA directed con-
structs we used the previously published2 sequence ‘CT19’ -5′-GAGACATAAACTGGCCAAC-3′ cloned into 
pSilencer2.1. qPCR for ank3 mRNA was conducted following Qiagen RNeasy plus - aided (Qiagen, Hilden, 
Germany) RNA isolation, reverse transcription using random hexamer primers and using the following prim-
ers, rat ank3, FW 5′-GTGCATTCTGGGTTTCTGGT-3′, REV 5′-CACTATGACCGGGCCTAAAA-3′ 18S, 
FW-5′-GTAACCCGTTGAACCCCATT-3′, REV 5′-CCATCCAATCGGTAGTAGCG-3′ on a Roche Lightcycler 
2.0 (Roche, Penzberg, Germany) with SYBRgreen (Quantitect, SYBRgreen kit, Qiagen) using manufacturers’s 
instructions.
Chromatin-Immunoprecipitation (ChIP) analysis. Cell culture of a murine BV-2 cell line was con-
ducted using RPMI, 10% FBS, 2 mM Glutamine, 1% Penicllin/Streptomycin, the cells were stimulated using 
100 ng/ml rmTNF-α (PeproTech, London, UK), 2 hours before fixation in 1% formaldehyde, left at 37 °C for 
10 min and quenched with 2 mM Glycine. Following pellet washes, resuspension in sonication buffer followed 
(1% Triton X-100, 0.1% Na-deoxycholate, 50 mM Tris-Cl, pH 8.10, 150 mM NaCl, 5 mM EDTA, 0.1% PMSF, 
1% SDS and protease inhibitor cocktail) and sonication on full power for 3 × 10 sec on ice (Branson Digital 
Sonifier 250, Danbury, USA). The cells were spun at 13,000 rpm for 2 min. Supernatants underwent agarose gel 
electrophoresis for fragment length check (400–600 bp) and were used for immunoprecipitation. To protein 
A/G-agarose, FBS and Fish Sperm DNA (Sigma) was added and incubated for 30 mins for preclearing, with 5 μl 
of rabbit monoclonal anti-p65 (D14E12, CST) for immunoprecipitation overnight at 4 °C. Samples were spun 
and underwent series of washing steps before extraction of DNA using 1% SDS, 0.1% NaHCO3. The samples were 
incubated at 65 °C for 2–4 hours and purified using a PCR purification kit. PCR was conducted using standard 
procedures at 45 cycles using the following primer pairs (5′ -> 3′): ‘7’-CTGGCCTTCTGGGTCTCATTTACGC & 
‘8’-CGGGTGTGGTCGCTTAAGCATCTTT, ‘3’-TTAAGCGACCACACCCGACAGT & ‘2’-CAAAAGGT 
TCAGCCCCTGGCTTT, ‘4’-CGTTACCACCCCCACTGCTG & ‘6’-AAAGGGGGAGGCATACGTGCAT, 
‘32’-GGAAGGAAGAAAACAAAGGGTTGGAA & ‘33’-CAGGGGAGTTGAGACGAGGC.
Statistical analysis. We employed GraphPad Prism for statistical analyses (GraphPad Software Inc., La 
Jolla, USA). Significance was determined following parametric testing and using the test as detailed in the figure 
legends. All data are represented as mean ± SEM, data values are represented by a circle, p values ≤ 0.05 were 
considered to be significantly different and marked by an asterisk.
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